- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04487054
Outcomes of Early Palliative Care Intervention for High-Risk Patients in the Intensive Care Unit-A Pilot Study
Outcomes of Early Palliative Care Intervention for High-Risk Patients in the Intensive Care Unit- A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The emerging challenge in critical care medicine focuses on improving patient- and family-centered outcomes. (1) The gold standard for patient-centered care is that which aligns with patients' values, preferences, and goals. (2) Palliative care consultants are known for utilizing shared decision making conversations in the intensive care unit (ICU) in which they elicit patients' values and goals. Accurate prognostic information based on the patient's overall condition sets the context for shared decision-making. With the gravity of the decisions made every day in the ICU, prognostic information is invaluable to patients, families, and clinicians. Historically, prognostic models in the ICU have focused on short-term mortality, such as death prior to hospital discharge, but studies have shown that information about post-ICU quality of life outcomes is important to patients and families as is information about survival for six months or more. Researchers have identified that future work in ICU prognostication must focus on accurately predicting the scope of patient-centered outcomes without losing sight of the higher mortality risk faced by ICU patients and survivors. The investigators propose to perform a proof of concept study based on our previously validated integrated prognostic model to identify medical ICU patients with high risk of mortality in six months and determine the utility of this model in terms of improving quality of life and quality of care. The study will consist of two 4-month time periods: usual care and usual care + targeted pro-active palliative care intervention within 48 hours of ICU admission, respectively. For both phases, the investigators will use the previously validated and published integrated prognostic model consisting of the 'surprise question' of "Would you be surprised if this patient died in the next six months?" with a response of "No", the APACHE IV score, and the Charlson Comorbidity Index (CCI) score to identify ICU patients within 24 hours of their ICU admission with a probability estimate of six-month mortality greater than 40 percent.
Six weeks after ICU discharge, we will contact the legal decision maker for the patient (family member or friend who is the medical power of attorney or healthcare surrogate) regarding their satisfaction with critical care services the patient received during the ICU stay. After obtaining verbal consent, questions will be asked from the modified Family Survey-ICU (FS-ICU) and the global performance measure #18 from the Bereaved Family Survey (BFS). The investigators hypothesize that the systematic identification of ICU patients at highest risk of six-month mortality as a prompt for a targeted pro-active palliative care approach will decrease length of ICU and hospital stay, reduce ICU readmissions, lead to earlier treatment limitation orders according to patients' wishes, and increase family satisfaction with the quality of care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26506
- West Virginia University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients greater than 18 years of age admitted to the medical ICU at West Virginia University Hospital.
- Patients with a predicted six-month mortality greater than 40% on the integrated prognostic model.
- Patients who live longer than 48 hours after medical ICU admission.
Exclusion Criteria:
- Patient who did not meet inclusion criteria will be excluded.
- Pregnant female/incarcerated patients will be excluded.
- Since this is a study in an adult patient population, children will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
Subjects in the ICU with a poor prognosis will receive usual care in time period one.
|
|
|
Experimental: Usual care plus palliative care
Subjects in the ICU with a poor prognosis will receive usual care plus targeted pro-active palliative care intervention within 48 hours of ICU admission in time period two.
|
Patient with high risk of mortality in ICU will be identified using our previously validated prognostic model.
Intervention phase will employ pro-active palliative care on eligible patients after they survive 48 hours in ICU.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length Of Stay (LOS) in the medical ICU
Time Frame: From enrollment to Discharge from the ICU, an average of 24 weeks
|
Number of days subject was admitted to the medical ICU
|
From enrollment to Discharge from the ICU, an average of 24 weeks
|
|
Length Of Stay in hospital
Time Frame: From enrollment to Discharge from the hospital, an average of 24 weeks
|
Number of total days subject was hospitalized
|
From enrollment to Discharge from the hospital, an average of 24 weeks
|
|
Medical ICU re-admission during the hospital stay
Time Frame: From enrollment to discharge from the hospital, up to 16 weeks
|
Number of times a patient was re-admitted to the medical ICU
|
From enrollment to discharge from the hospital, up to 16 weeks
|
|
Treatment limitation orders within 48 hours of admission
Time Frame: From enrollment to discharge from the hospital, an average of 24 weeks
|
Count of subjects that had or completed any treatment limitation orders (do-not-resuscitate, do-not-intubate, no vasopressors, etc) within 48 hours of admission
|
From enrollment to discharge from the hospital, an average of 24 weeks
|
|
Family satisfaction with care in ICU
Time Frame: From enrollment to six weeks post ICU discharge
|
Six-weeks post discharge, a telephone survey will be conducted with health care surrogate or medical power attorney to determine their satisfaction with the care received in ICU. 5 point scale with 1= very dissatisfied and 5= Completely Satisfied
|
From enrollment to six weeks post ICU discharge
|
|
Advance directive completion
Time Frame: From enrollment to hospital discharge, an average of 24 weeks
|
Difference in completion rate of advance directives [a written statement of a person's wishes regarding medical treatment] between the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to hospital discharge, an average of 24 weeks
|
|
Physician Orders for Scope of Treatment (POST) form completion
Time Frame: From enrollment to hospital discharge, an average of 24 weeks
|
Difference in completion rate of the Physician Orders for scope of Treatment (POST) form between the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to hospital discharge, an average of 24 weeks
|
|
Discharge Outcome Location-Home
Time Frame: From enrollment to six weeks post ICU discharge
|
Difference in discharge outcome location from the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to six weeks post ICU discharge
|
|
Discharge Outcome Location-Skilled Nursing Facility
Time Frame: From enrollment to six weeks post ICU discharge
|
Difference in discharge outcome location from the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to six weeks post ICU discharge
|
|
Discharge Outcome Location-LTACH
Time Frame: From enrollment to six weeks post ICU discharge
|
Difference in discharge outcome location from the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to six weeks post ICU discharge
|
|
Discharge outcomes-Death
Time Frame: From enrollment to six weeks post ICU discharge
|
Difference in discharge outcome location from the baseline period (Standard of Care Patients) and following the intervention (Early Palliative Care Patients)
|
From enrollment to six weeks post ICU discharge
|
|
Site of death-ICU
Time Frame: From enrollment to six weeks post ICU discharge
|
Count of subjects that passed in specific locations.
|
From enrollment to six weeks post ICU discharge
|
|
Site of death-Hospital
Time Frame: From enrollment to six weeks post ICU discharge
|
Count of subjects that passed in specific locations.
|
From enrollment to six weeks post ICU discharge
|
|
Site of death-Home
Time Frame: From enrollment to six weeks post ICU discharge
|
Count of subjects that passed in specific locations.
|
From enrollment to six weeks post ICU discharge
|
|
Site of death-Hospice
Time Frame: From enrollment to six weeks post ICU discharge
|
Count of subjects that passed in specific locations.
|
From enrollment to six weeks post ICU discharge
|
|
Site of death-Skilled Nursing Facility
Time Frame: From enrollment to six weeks post ICU discharge
|
Count of subjects that passed in specific locations.
|
From enrollment to six weeks post ICU discharge
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1711863473
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palliative Care
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPalliative Care | Palliative Medicine | Hospice and Palliative Care NursingItaly
-
University Medical Center GoettingenRecruitingPalliative Care | Palliative Care, Patient Care | Oral Health Care | Oral Health-Related Quality of LifeGermany
-
Norfolk and Norwich University Hospitals NHS Foundation...Manchester Centre for Genomic Medicine - St. Mary's Hospital University of...Enrolling by invitationPalliative Care | Supportive CareUnited Kingdom
-
Mayo ClinicCompletedPalliative Care | Transitional CareUnited States
-
McMaster UniversityUnknownPalliative Care | Satisfaction | Primary CareCanada
-
Bandırma Onyedi Eylül UniversityEge UniversityRecruitingPalliative CareTurkey
-
Cudeca Hospice FoundationLa Caixa FoundationRecruiting
-
Fordham UniversityCalvary Hospital, Bronx, NYNot yet recruiting
-
University Hospitals of Derby and Burton NHS Foundation...University Hospitals, LeicesterCompleted
-
Centre Hospitalier William Morey - Chalon sur SaôneCompleted
Clinical Trials on Pro-active palliative care
-
Allina Health SystemCompleted
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaboratorsCompletedDysphagiaUnited States, Canada
-
Augusto CaraceniRecruitingCancer | Frailty | Palliative Care | Outpatient | Palliative Care, Health Services | Patient Reported Outcome Measurements | Patient Reported Outcome (PRO)Italy
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Palliative Care Research Cooperative...CompletedLung CancerUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompletedPalliative Care | Renal Failure, End-stageHong Kong
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedHeart Diseases | Cardiovascular Diseases | Heart FailureUnited States
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States